The S&P/ASX Small Ordinaries Index (ASX:XSO) slipped 25.1 points, or 0.74%, to 3,367.6, extending its five-day decline to ...

Small-cap stocks posted a blistering performance in the first half of this year. The Russell 2000 Index surged 22% through June, marking its strongest first-half performance since 1991. It also beat ...

The Russell 2000 Index has surged nearly 22% this year, posting its best first-half performance since 1991. "It's both a valuation catch-up story and a fundamental story," said Amy Zhang, portfolio ...

In this article, we will be taking a look at the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Tom Lee of Fundstrat spoke on CNBC’s Closing Bell on June 9 about chip stocks, ...

India's pharmaceutical sector continues to offer compelling long-term opportunities, particularly in innovation-led ...

The Biotech Growth Trust PLC - Eli Lilly to acquire BIOG portfolio company, AtaiBeckley Inc. PR Newswire LONDON, United Kingdom, July 17 17 July 2026 ...

June 29 (Reuters) - Ipsen (IPN.PA), opens new tab will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline ‌with a late-stage blood cancer treatment, the French biotech ...

The S&P/ASX Small Ordinaries Index (XSO) finished slightly weaker yesterday, slipping 5.30 points, or 0.15%, to 3,434.50.

Electrovaya Inc. (ELVA-T) shares surged on Wednesday after the lithium-ion battery technology and manufacturing company ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. This should not be construed as financial or investment advice. Trading involves ...